State Street Corp Spero Therapeutics, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 148,911 shares of SPRO stock, worth $433,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,911
Previous 148,911
-0.0%
Holding current value
$433,331
Previous $154,000
30.52%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SPRO
# of Institutions
43Shares Held
14.4MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX3.8MShares$11.1 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$5.13 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.94 Million14.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$2.83 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.59 Million0.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $102M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...